Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Trial in progress: A phase II, multicentre study to evaluate the efficacy and safety of birelentinib (DZD8586) combination therapy in diffuse large B-cell lymphoma (TAI-SHAN12)

Huiqiang Huang, Wenyu Li, Liqun Zou, Yajun Li, Fang Zhu, Keshu Zhou, Yun Liang, Meifang Zheng, Zengjun Li, Hongmei Jing, Wei Yang, Pengcheng He, Kaiyang Ding, Yuhua Li, Mengling Zhong, Ziyi Liu, Liping Su

Blood (2025) 146 (Supplement 1): 8238.

https://doi.org/10.1182/blood-2025-8238

Published: 2025

Journal Articles

Updated results of TQB2934, a novel 2+1 BCMA × CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma: A phase I study

Yian Zhang, Bingzong Li, Junling Zhuang, Pengcheng He, Xingli Zhao, Baijun Fang, Songfu Jiang, Bing Chen, Zhongjun Xia, Zhenyu Li, Zengjun Li, Haifeng Zhao, Dawei Ding, Qianqian Zhang, Xunqiang Wang, Peng Liu

Blood (2025) 146 (Supplement 1): 2279.

https://doi.org/10.1182/blood-2025-2279

Published: 2025

Journal Articles

Preliminary efficacy and safety of TT-01488, a novel, non-covalent, reversible BTK inhibitor, in patients with relapsed/refractory mantle cell lymphoma

Blood (2025) 146 (Supplement 1): 1824.

https://doi.org/10.1182/blood-2025-1824

Published: 2025

Journal Articles

Mitoxantrone hydrochloride liposome injection combined with thiotepa-busulfan-fludarabine (MTBF) as conditioning regimen in patients undergoing allogeneic hematopoietic stem cell transplantation for central nervous system leukemia:a single-center retrospective case-control study

Yuqi Wang, Xintong Zhang, Juan Ren, Pengcheng He, Xiaoning Wang

Blood (2025) 146 (Supplement 1): 2423.

https://doi.org/10.1182/blood-2025-2423

Published: 2025

Journal Articles

High-affinity PD-1-CD28 switch receptor enhances sustained antitumor activity of CAR-T cells in both lymphoma and ewing sarcoma.

Hanzhi Du, MD, Helong Gong, Yidan Wang, Zihang Li, PhD, Kaijing Chang, Sirui Duan, Qiuyi Ma, Huachao Zhu, Di Wu, MD, Stefan Burdach, MD, PhD, Jürgen Ruland, MD, PhD, Pengcheng He, MD, PhD, Busheng Xue, MD

Blood (2025) 146 (Supplement 1): 4102.

https://doi.org/10.1182/blood-2025-4102

Published: 2025

Journal Articles

Initial Results of the first-in-human Phase 1 study of IBI3003, a novel trispecific antibody targeting GPRC5D, BCMA and CD3, in patients with relapsed or refractory multiple myeloma

Jing Li, Zhenyu Li, Chunrui Li, Pengcheng He, Jun Luo, Rong Fu, Liye Zhong, Hang Quach, Jay Hocking, Peter Presgrave, Xiaoyi Tang, Wen Zhang, Jinchao Gao, Luyin Ding, Peiqi Li, Hui Zhou, Peng Liu

Blood (2025) 146 (Supplement 1): 702.

https://doi.org/10.1182/blood-2025-702

Published: 2025

Journal Articles

Phase 1/2, multi-center, open-label clinical study to evaluate the safety, pharmacokinetics, and efficacy of zefamenib in patients with relapsed/refractory acute leukemia

Blood (2025) 146 (Supplement 1): 5209.

https://doi.org/10.1182/blood-2025-5209

Published: 2025

Journal Articles

Efficacy and safety results of TQB3909，a novel BCL-2 inhibitor, in combination with azacitidine for patients with myeloid malignancies

Jianxiang Wang, Guanchen Bai, Pengcheng He, Hao Jiang, Fuling Zhou, Wei Yang, Xingli Zhao, Shuning Wei, Zhen Wang, Wenwei Zhu, Lin Geng, Zhihua Zhang, Jianhua Qu, Jie Zhou, Tiejun Gong, Ligen Liu, Junfeng Zhu

Blood (2025) 146 (Supplement 1): 5196.

https://doi.org/10.1182/blood-2025-5196

Published: 2025

Journal Articles

Insights from a multicenter study on the outcomes of liver abscess after allogeneic hematopoietic stem cell transplantation

Blood (2025) 146 (Supplement 1): 4267.

https://doi.org/10.1182/blood-2025-4267

Published: 2025

Journal Articles

Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: Lessons learned from a national representative study

Peng Zhao, Zhixue Li, Erlie Jiang, Shengjin Fan, Pengcheng He, Jingzhi Wang, Linghui Xia, Qiu-Sha Huang, Jin Wu, Zhuoyu An, Hai-Xia Fu, Yuanyuan Zhang, Xiangyu Zhao, Yu Wang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 4263.

https://doi.org/10.1182/blood-2025-4263

Published: 2025

Journal Articles

Effectiveness and safety of polatuzumab vedotin in real-world clinical practice in Chinese patients with diffuse large B-cell lymphoma (POLAREAL): An interim analysis from a prospective, multicenter, observational registry study

Blood (2025) 146 (Supplement 1): 6293.

https://doi.org/10.1182/blood-2025-6293

Published: 2025

Journal Articles

Efficacy and safety profile of inaticabtagene autoleucel in Chinese patients with B-cell acute lymphoblastic leukemia: Insights from real-world data

Blood (2025) 146 (Supplement 1): 5122.

https://doi.org/10.1182/blood-2025-5122

Published: 2025

Journal Articles

Efficacy and safety of mitoxantrone hydrochloride liposome in peripheral T-cell lymphoma: A multicenter, non-interventional, ambispective cohort real-world study

Blood (2025) 146 (Supplement 1): 1878.

https://doi.org/10.1182/blood-2025-1878

Published: 2025

Journal Articles

Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection Combined with Carmustine, Etoposide and Cytarabine As Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Non-Hodgkin Lymphoma Patients

Xiaoning Wang, Yuqi Wang, Juan Ren, Huachao Zhu, Pengcheng He

Blood (2024) 144 (Supplement 1): 7114.

https://doi.org/10.1182/blood-2024-201937

Published: 2024

Journal Articles

Phase 1 Study of TT-01488, a Novel, Non-Covalent, Reversible BTK Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies

Yufu Li, Wei Xu, Caixia Li, Pengcheng He, Wei Yang, Xiangmin Tong, Ying Wang, Hongchan Zhang, Caixia Sun, Zejuan Sheng, Jean Fan, Jianyong Li

Blood (2024) 144 (Supplement 1): 3036.

https://doi.org/10.1182/blood-2024-202976

Published: 2024

Journal Articles

Efficacy and Safety of Mitoxantrone Hydrochloride Liposome in Combination with Thiotepa-Busulfan-Fludarabine As an Intensive Conditioning Regimen Preceding Salvage Allogeneic Stem Cell Transplantation in Relapsed or Refractory Acute Myeloid Leukemia

Xiaoning Wang, Juan Ren, Huachao Zhu, Yuqi Wang, Pengcheng He

Blood (2024) 144 (Supplement 1): 2107.

https://doi.org/10.1182/blood-2024-204514

Published: 2024

Journal Articles

Zanubrutinib Plus R-CHOP (ZR-CHOP) in Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients Who Were Positron Emission Tomography-Positive after Two Cycles of R-CHOP: A Single-Arm, Open-Label, Multicenter Prospective Study

Jie Wang, He Li, Chenlu Yang, Di Wu, Xingli Zou, Tao Yang, Liangliang Ma, Fang Xu, Jie Wang, Minggang Su, Sha Zhao, Lin Ji, Yao Liu, Pengcheng He, Ting Niu

Blood (2024) 144 (Supplement 1): 4488.

https://doi.org/10.1182/blood-2024-193927

Published: 2024

Journal Articles

ABO Incompatibility Haploidentical Peripheral Blood Stem Cell Transplantation Combined with a Single Cord Blood Unit for Severe Aplastic Anemia Patients

Xiaoning Wang, Juan Ren, Huachao Zhu, Mei Zhang, Pengcheng He

Blood (2023) 142 (Supplement 1): 6973.

https://doi.org/10.1182/blood-2023-172898

Published: 2023

Journal Articles

The Effects of Mycophenolate Mofetil and Cyclosporine with Concomitant Posaconazole Tablets in the Early Stage of Allogeneic Hematopoietic Stem Cell Transplantation

Xiaoning Wang, Juan Ren, Huachao Zhu, Mei Zhang, Pengcheng He

Blood (2023) 142 (Supplement 1): 7015.

https://doi.org/10.1182/blood-2023-174675

Published: 2023

Journal Articles

A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial of HH2853 in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-Cell Lymphoma

Huangming Hong, Mingzhi Zhang, Zhigang Peng, Jianzhen Shen, Yuerong Shuang, Hui Zhou, Hongqiang Guo, He Huang, Fei Li, Zhengzi Qian, Lihong Liu, Liang Wang, Wei Yang, Liling Zhang, Pengcheng He, Shen Qian, Fugen Li, Meng Li, Tongyu Lin

Blood (2023) 142 (Supplement 1): 304.

https://doi.org/10.1182/blood-2023-180372

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Trial in progress: A phase II, multicentre study to evaluate the efficacy and safety of birelentinib (DZD8586) combination therapy in diffuse large B-cell lymphoma (TAI-SHAN12)

Updated results of TQB2934, a novel 2+1 BCMA × CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma: A phase I study

Preliminary efficacy and safety of TT-01488, a novel, non-covalent, reversible BTK inhibitor, in patients with relapsed/refractory mantle cell lymphoma

Mitoxantrone hydrochloride liposome injection combined with thiotepa-busulfan-fludarabine (MTBF) as conditioning regimen in patients undergoing allogeneic hematopoietic stem cell transplantation for central nervous system leukemia:a single-center retrospective case-control study

High-affinity PD-1-CD28 switch receptor enhances sustained antitumor activity of CAR-T cells in both lymphoma and ewing sarcoma.

Initial Results of the first-in-human Phase 1 study of IBI3003, a novel trispecific antibody targeting GPRC5D, BCMA and CD3, in patients with relapsed or refractory multiple myeloma

Phase 1/2, multi-center, open-label clinical study to evaluate the safety, pharmacokinetics, and efficacy of zefamenib in patients with relapsed/refractory acute leukemia

Efficacy and safety results of TQB3909，a novel BCL-2 inhibitor, in combination with azacitidine for patients with myeloid malignancies

Insights from a multicenter study on the outcomes of liver abscess after allogeneic hematopoietic stem cell transplantation

Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: Lessons learned from a national representative study

Effectiveness and safety of polatuzumab vedotin in real-world clinical practice in Chinese patients with diffuse large B-cell lymphoma (POLAREAL): An interim analysis from a prospective, multicenter, observational registry study

Efficacy and safety profile of inaticabtagene autoleucel in Chinese patients with B-cell acute lymphoblastic leukemia: Insights from real-world data

Efficacy and safety of mitoxantrone hydrochloride liposome in peripheral T-cell lymphoma: A multicenter, non-interventional, ambispective cohort real-world study

Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection Combined with Carmustine, Etoposide and Cytarabine As Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Non-Hodgkin Lymphoma Patients

Phase 1 Study of TT-01488, a Novel, Non-Covalent, Reversible BTK Inhibitor, in Patients with Relapsed or Refractory B-Cell Malignancies

Efficacy and Safety of Mitoxantrone Hydrochloride Liposome in Combination with Thiotepa-Busulfan-Fludarabine As an Intensive Conditioning Regimen Preceding Salvage Allogeneic Stem Cell Transplantation in Relapsed or Refractory Acute Myeloid Leukemia

Zanubrutinib Plus R-CHOP (ZR-CHOP) in Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients Who Were Positron Emission Tomography-Positive after Two Cycles of R-CHOP: A Single-Arm, Open-Label, Multicenter Prospective Study

ABO Incompatibility Haploidentical Peripheral Blood Stem Cell Transplantation Combined with a Single Cord Blood Unit for Severe Aplastic Anemia Patients

The Effects of Mycophenolate Mofetil and Cyclosporine with Concomitant Posaconazole Tablets in the Early Stage of Allogeneic Hematopoietic Stem Cell Transplantation

A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial of HH2853 in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only